(Q36733146)

16 August 2017

1 reference

title

Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening (English)

1 reference

16 August 2017

0 references

human papilloma virus

object named as

Human papilloma virus

1 reference

Adams M

1

1 reference

16 August 2017

Jasani B

series ordinal

2

1 reference

16 August 2017

Fiander A

series ordinal

3

1 reference

16 August 2017

language of work or name

English

0 references

publication date

18 January 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

25

1 reference

16 August 2017

issue

16

1 reference

16 August 2017

page(s)

3007-3013

1 reference

The causal relation between human papillomavirus and cervical cancer

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.016

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.016

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.016

The cervical cancer epidemic that screening has prevented in the UK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.016

Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.016

Benefit of cervical screening at different ages: evidence from the UK audit of screening histories

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.016

Cervical screening in the National Breast and Cervical Cancer Early Detection Program, 1995-2001

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.016

Psychological effects of a low-grade abnormal cervical smear test result: anxiety and associated factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.016

Can glandular lesions be diagnosed in pap smear cytology?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.016

Cervical cancer in the Netherlands 1989-1998: Decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.016

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.016

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.016

Chapter 13: Current findings from prophylactic HPV vaccine trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.016

Against which human papillomavirus types shall we vaccinate and screen? The international perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.016

Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.016

Human papillomavirus genotype distribution in low-grade cervical lesions: comparison by geographic region and with cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.016

Evaluating human papillomavirus vaccination programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.016

Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.016

Chapter 24: Psychosocial aspects of vaccine acceptability.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.016

Future acceptance of adolescent human papillomavirus vaccination: a survey of parental attitudes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.01.016

10.1016/J.VACCINE.2007.01.016

7 January 2021

Identifiers

DOI

1 reference

16 August 2017

1 reference